Journal article · 2022 · Open access

Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children

Xiaohe Li, Liwen Wu, Youzhi Qu, Mengli Cao, Jiaqi Feng, Hua Huang, Yi Liu, Quanying Liu, Quanying Liu, Yingxia Liu

Signal Transduction and Targeted Therapy, 7(1), 203 · Published 28 June 2022 · DOI 10.1038/s41392-022-01023-w

Open PDFView at the publisherCite this paper

In brief

“Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children” is a 2022 journal article by Xiaohe Li and 9 co-authors, published in Signal Transduction and Targeted Therapy. OpenAlex counts 11 citations as of 18 November 2026, which puts it in the top 7% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.

Citations
11
Most cited in
2023 (6)
Field-weighted impact
1.34
References
5
Authors
10

Abstract

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly replaced the Delta variant as a dominating SARS-CoV-2 variant because of natural selection, which favors the variant with higher infectivity and stronger vaccine breakthrough ability. 1 Among three lineages BA.1 (B.1.1.529.1), BA.2 (B.1.1.529.2), and BA.3 (B.1.1.529.3) of Omicron, BA.2 is rising rapidly worldwide since January 2022 and become a new dominating “variant of concern” in China. 2 With the current surge in Omicron in China, both the absolute number of children hospitalized with COVID-19 and the percentage of total COVID-19 hospitalizations have been boosting recently. Understanding the clinical characteristics of SARS-CoV-2 Omicron subvariant BA.2 in children and the protective effect of vaccines is of great help for epidemic prevention strategies. However, so far no sufficient experimental data have been reported about infectivity, disease severity, vaccine breakthrough capability, and antibody resistance from pediatric BA.2.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Li, X., Wu, L., Qu, Y., Cao, M., Feng, J., Huang, H., Liu, Y., Liu, Q., Liu, Q., & Liu, Y. (2022). Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children. Signal Transduction and Targeted Therapy, 7(1), 203. https://doi.org/10.1038/s41392-022-01023-w

MLA 9

Li, Xiaohe, et al. “Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children.” Signal Transduction and Targeted Therapy, vol. 7, no. 1, 2022, p. 203. https://doi.org/10.1038/s41392-022-01023-w.

Chicago

Li, Xiaohe, Liwen Wu, Youzhi Qu, Mengli Cao, Jiaqi Feng, Hua Huang, Yi Liu, Quanying Liu, Quanying Liu, and Yingxia Liu. 2022. “Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children.” Signal Transduction and Targeted Therapy 7 (1): 203. https://doi.org/10.1038/s41392-022-01023-w.

Harvard

Li, X. et al. (2022) ‘Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children’, Signal Transduction and Targeted Therapy, 7(1), p. 203. doi:10.1038/s41392-022-01023-w.

IEEE

X. Li et al., “Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children,” Signal Transduction and Targeted Therapy, vol. 7, no. 1, p. 203, 2022, doi: 10.1038/s41392-022-01023-w.

BibTeX

@article{li2022clinical,
  title     = {{Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children}},
  author    = {Li, Xiaohe and Wu, Liwen and Qu, Youzhi and Cao, Mengli and Feng, Jiaqi and Huang, Hua and Liu, Yi and Liu, Quanying and Liu, Quanying and Liu, Yingxia},
  journal   = {Signal Transduction and Targeted Therapy},
  year      = {2022},
  volume    = {7},
  number    = {1},
  pages     = {203},
  doi       = {10.1038/s41392-022-01023-w},
  url       = {https://doi.org/10.1038/s41392-022-01023-w}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202233
202366
202522

Its field-weighted citation impact is 1.34: it has been cited 1.34 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research

  • pediatric COVID-19
  • vaccine effectiveness
  • breakthrough infection
  • clinical features
  • disease severity
  • antibody resistance
  • variants of concern
  • COVID-19 hospitalization

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Li, X., Wu, L., Qu, Y., Cao, M., Feng, J., Huang, H., Liu, Y., Liu, Q., Liu, Q., & Liu, Y. (2022). Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children. Signal Transduction and Targeted Therapy, 7(1), 203. https://doi.org/10.1038/s41392-022-01023-w

How many times has this paper been cited?

11 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Signal Transduction and Targeted Therapy: sign in and open the PDF from this page.

Who wrote this paper?

Xiaohe Li, Liwen Wu, Youzhi Qu, Mengli Cao, Jiaqi Feng, Hua Huang, Yi Liu, Quanying Liu, Quanying Liu, Yingxia Liu.

What is the DOI of this paper?

10.1038/s41392-022-01023-w, permanently at https://doi.org/10.1038/s41392-022-01023-w. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.